Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism

Adv Neurol. 1993:60:251-8.
No abstract available

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacokinetics
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology*
  • Animals
  • Brain / drug effects*
  • Brain / physiopathology
  • Calcium / physiology*
  • Calcium Channels / drug effects
  • Calcium Channels / physiology
  • Cell Death / drug effects
  • Cell Death / physiology
  • Corpus Striatum / drug effects
  • Corpus Striatum / physiopathology
  • Dopamine / metabolism*
  • Free Radicals
  • Hydroxides / metabolism*
  • Hydroxyl Radical
  • Iron / physiology
  • Monoamine Oxidase / physiology
  • Nerve Degeneration / drug effects
  • Nerve Degeneration / physiology
  • Neural Pathways / drug effects
  • Neural Pathways / physiopathology
  • Oxidation-Reduction
  • Parkinson Disease, Secondary / chemically induced*
  • Parkinson Disease, Secondary / physiopathology
  • Potassium / physiology
  • Potassium Channels / drug effects
  • Potassium Channels / physiology
  • Rats
  • Substantia Nigra / drug effects*
  • Substantia Nigra / physiopathology

Substances

  • Calcium Channels
  • Free Radicals
  • Hydroxides
  • Potassium Channels
  • Hydroxyl Radical
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Iron
  • Monoamine Oxidase
  • Potassium
  • Calcium
  • Dopamine